NEW YORK – Fluxergy said on Monday that it is collaborating with Mass General Brigham (MGB, formerly Partners Healthcare) to evaluate Fluxergy's research-use-only COVID-19 molecular testing platform.
Fluxergy, based in Irvine, California, will specifically work with the MGB Center for COVID Innovation, said Fluxergy Chief Commercialization Officer Ali Tinazli.